MSH2 and neoplasm: The nuclear expression of MSH2 and MSH6 proteins in cancer cells confirms the possibility of mismatch repair deficiency (MMR-D) in the tumor DNA, suggesting MSI-H and MSH2 germline mutation (Lynch syndrome).